Biblio

Zhang H, Lipinski AA, Liktor-Busa E, Smith AF, Moutal A, Khanna R, Langlais PR, Largent-Milnes TM, Vanderah TW.  2021.  The Effects of Repeated Morphine Treatment on the Endogenous Cannabinoid System in the Ventral Tegmental Area.. Front Pharmacol. 12:632757.

Moffett C, Kost KJ, Thompson A, Ossipov M, Perolizzi, Jr JV, Umeda-Raffa S, Raffa RB, Largent-Milnes TM, Vanderah T.  2021.  The FDA Mandate to Reassess Benzodiazepines: Alprazolam Induces a Positive Conditioned Place-Preference if Male Rate. Journal of Biosciences and Medicines. 9:1-8.

Blawn KT, Kellohen KL, Galloway EA, Wahl J, Vivek A, Verkhovsky VG, Barker NK, Cottier KE, Vallecillo TG, Langlais PR et al..  2021.  Sex hormones regulate NHE1 functional expression and brain endothelial proteome to control paracellular integrity of the blood endothelial barrier.. Brain Res. 1763:147448.

Levine A, Vanderah TW, Largent-Milnes TM.  2021.  An underrepresented majority: A systematic review utilizing allodynic criteria to examine the present scarcity of discrete animal models for episodic migraine.. Cephalalgia. 41(3):404-416.

Doyle TM, Janes K, Chen Z, Grace PM, Esposito E, Cuzzocrea S, Largent-Milnes TM, Neumann WL, Watkins LR, Spiegel S et al..  2020.  Activation of sphingosine-1-phosphate receptor subtype 1 in the central nervous system contributes to morphine-induced hyperalgesia and antinociceptive tolerance in rodents.. Pain. 161(9):2107-2118.

Wiese BM, Liktor-Busa E, Levine A, Couture SA, Nikas SP, Ji L, Liu Y, Mackie K, Makriyannis A, Largent-Milnes TM et al..  2020.  Cannabinoid-2 Agonism with AM2301 Mitigates Morphine-Induced Respiratory Depression.. Cannabis Cannabinoid Res.

Levine A, Liktor-Busa E, Karlage KL, Giancotti L, Salvemini D, Vanderah TW, Largent-Milnes TM.  2020.  DAGLα Inhibition as a Non-invasive and Translational Model of Episodic Headache.. Front Pharmacol. 11:615028.

Thompson AL, Grenald SA, Ciccone HA, BassiriRad N, Niphakis MJ, Cravatt BF, Largent-Milnes TM, Vanderah TW.  2020.  The Endocannabinoid System Alleviates Pain in a Murine Model of Cancer-Induced Bone Pain.. J Pharmacol Exp Ther. 373(2):230-238.

Liktor-Busa E, Blawn KT, Kellohen KL, Wiese BM, Verkhovsky V, Wahl J, Vivek A, Palomino SM, Davis TP, Vanderah TW et al..  2020.  Functional NHE1 expression is critical to blood brain barrier integrity and sumatriptan blood to brain uptake.. PLoS One. 15(5):e0227463.

Zhang H, Largent-Milnes TM, Vanderah TW.  2020.  Glial neuroimmune signaling in opioid reward.. Brain Res Bull. 155:102-111.

Smith AF, Vanderah TW, Erickson RP.  2020.  Haploinsufficiency of tau decreases survival of the mouse model of Niemann-Pick disease type C1 but does not alter tau phosphorylation.. J Appl Genet. 61(4):567-570.

Bartlett MJ, So LY, Szabò L, Skinner DP, Parent KL, Heien ML, Vanderah TW, Polt R, Sherman SJ, Falk T.  2020.  Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model.. BMC Res Notes. 13(1):149.

Johnston B, Vanderah TW.  2020.  Lost in the Haze: The Physician's Role in Cannabinoid Prescribing and Advising.. Am J Med. 133(1):7-8.

Ellingson HM, Vanderah TW.  2020.  Potential therapeutic treatments of cancer-induced bone pain.. Curr Opin Support Palliat Care. 14(2):107-111.

Thompson AL, Largent-Milnes TM, Vanderah TW.  2019.  Animal Models for the Study of Bone-Derived Pain.. Methods Mol Biol. 1914:391-407.

Moutal A, Luo S, Largent-Milnes TM, Vanderah TW, Khanna R.  2019.  Cdk5-mediated CRMP2 phosphorylation is necessary and sufficient for peripheral neuropathic pain.. Neurobiol Pain. 5

Khanna R, Patwardhan A, Yang X, Li W, Cai S, Ji Y, Chew LA, Dorame A, Bellampalli SS, Schmoll RW et al..  2019.  Development and Characterization of An Injury-free Model of Functional Pain in Rats by Exposure to Red Light.. J Pain. 20(11):1293-1306.

, Vanderah TW, Largent-Milnes TM.  2019.  Migraine, A Review of Basic, Clinical, Translational Approaches to New Treatment. ARCH Women Health Care. 2(6):1-5.

Hay M, Polt R, Heien ML, Vanderah TW, Largent-Milnes TM, Rodgers K, Falk T, Bartlett MJ, Doyle KP, Konhilas JP.  2019.  A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction.. J Pharmacol Exp Ther. 369(1):9-25.

Chen Z, Doyle TM, Luongo L, Largent-Milnes TM, Giancotti LAntonio, Kolar G, Squillace S, Boccella S, Walker JK, Pendleton A et al..  2019.  Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain.. Proc Natl Acad Sci U S A. 116(21):10557-10562.

Pandit V, Khan M, Zakaria ERasheid, Largent-Milnes TM, Hamidi M, O'Keeffe T, Vanderah TW, Joseph B.  2018.  Continuous remote ischemic conditioning attenuates cognitive and motor deficits from moderate traumatic brain injury.. J Trauma Acute Care Surg. 85(1):48-53.

Edwards KA, Havelin JJ, McIntosh MI, Ciccone HA, Pangilinan K, Imbert I, Largent-Milnes TM, King T, Vanderah TW, Streicher JM.  2018.  A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain.. J Pain. 19(6):612-625.

Cottier KE, Galloway EA, Calabrese EC, Tome ME, Liktor-Busa E, Kim J, Davis TP, Vanderah TW, Largent-Milnes TM.  2018.  Loss of Blood-Brain Barrier Integrity in a KCl-Induced Model of Episodic Headache Enhances CNS Drug Delivery.. eNeuro. 5(4)

Zhang H, Lund DM, Ciccone HA, Staatz WD, Ibrahim MM, Largent-Milnes TM, Seltzman HH, Spigelman I, Vanderah TW.  2018.  Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain.. Pain. 159(9):1814-1823.

Watts GS, Youens-Clark K, Slepian MJ, Wolk DM, Oshiro MM, Metzger GS, Dhingra D, Cranmer LD, Hurwitz BL.  2017.  16S rRNA gene sequencing on a benchtop sequencer: accuracy for identification of clinically important bacteria.. J Appl Microbiol.